Hydrochlorothiazide, Aliskiren

RASILEZ HCT 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

12,5 mg + 150 mg comprimido recubierto con películaSpainWithdrawnAuthorised 9 Feb 2009

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Hydrochlorothiazide, Aliskiren

RASILEZ HCT 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

12,5 mg + 150 mg comprimido recubierto con películaSpainWithdrawnAuthorised 9 Feb 2009

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rasilez HCT 300/25MG Film Coated TabletSaudi Arabia · Novartis

Riprazo HCTEuropean Union · Novartis Europharm Ltd.

Sprimeo HCTEuropean Union · Novartis Europharm Ltd.

Packs

Pack	Code	Status
RASILEZ HCT 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos	672984

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Hydrochlorothiazide, Aliskiren
Strength: 12,5 mg + 150 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 9 Feb 2009
Registration: 08491012
Marketing authorisation holder: Noden Pharma Designated Activity Company
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

Hydrochlorothiazide + Aliskiren · 12,5 mg + 300 mg · comprimido recubierto con película

SpainWithdrawn

RASILEZ HCT 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULAHydrochlorothiazide + Aliskiren · 25 mg + 300 mg · comprimido recubierto con películaSpainWithdrawn